Having a partner with genital herpes does not mean you will inevitably catch it. In studies of couples where one person has herpes and the other does not, annual transmission rates without any precautions range from under 5 percent to roughly 30 percent, depending heavily on the direction of transmission, the susceptible partner’s prior immunity, and whether the couple uses condoms or antiviral medication. The risk is real but far from certain, and it drops substantially with a few well-studied interventions.
How Likely Is Transmission Without Any Precautions
The best data on “natural” transmission come from studies that tracked serodiscordant couples, meaning one partner tests positive for HSV-2 and the other tests negative. In a large randomized trial that included a placebo arm, about 3.6 percent of susceptible partners acquired HSV-2 over roughly eight months of follow-up when neither condoms nor daily antivirals were consistently used.1PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes That number is an average across both sexes. The actual risk for any given person varies widely based on biological factors that shift the odds in one direction or the other.
The clearest variable is sex. In heterosexual couples, women who have no prior antibodies to either HSV type face the highest annual acquisition rate, around 30 percent. Women who already carry antibodies to HSV-1 (the type that commonly causes cold sores) have a much lower rate, closer to 9 percent. Men acquiring HSV-2 from a female partner face the lowest risk, generally under 5 percent per year.2Infectious Disease Clinics of North America. Epidemiology of Genital Herpes Infections These figures come from an era before widespread suppressive antiviral use, so they reflect something close to the unmodified biological risk.
An earlier study of couples put the annual acquisition rate for susceptible women without any HSV antibodies at about 32 percent, dropping to roughly 9 percent among women who already had HSV-1 antibodies.3PubMed. Risk factors for the sexual transmission of genital herpes The consistency of these numbers across different studies from different decades gives them reasonable weight. The takeaway is that baseline risk is not one number. It depends on who you are, what antibodies you already carry, and which direction the virus would be traveling.
Why Herpes Spreads Even Between Outbreaks
One of the hardest things for couples to wrap their heads around is that herpes can transmit when the infected partner has no symptoms at all. The virus periodically reactivates and appears on genital skin without causing any visible sores. This is called asymptomatic shedding, and it accounts for a significant share of new infections.
In people with HSV-2, the frequency of this silent shedding changes over time. In the first year after a person’s initial outbreak, the virus shows up on genital skin on about a quarter of days sampled. Between one and nine years out, shedding drops to around 13 percent of days, and after a decade it falls further to roughly 9 percent.4PubMed Central. Persistent Genital Herpes Simplex Virus-2 Shedding Years Following the First Clinical Episode That means even people who have had herpes for many years still shed virus on close to one in ten days, usually without knowing it.
Genital HSV-1 behaves differently. In a study tracking people with first-episode genital HSV-1 infection, asymptomatic shedding was detected on about 11 percent of days in the first sampling period and dropped to roughly 5 percent of days later on.5JAMA. Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection So genital HSV-1 sheds less frequently than genital HSV-2, which partly explains why it is transmitted genitally less often in long-term relationships. Still, it is not zero.
The practical implication is that avoiding sex only during visible outbreaks reduces risk but does not eliminate it. Shedding happens on many days when the infected partner feels perfectly fine.
What Condoms Actually Do for Herpes Risk
Condoms help, but the degree of protection depends on which partner is infected and how consistently condoms are used. A pooled analysis of six large studies found that people who used condoms every single time had about a 30 percent lower risk of acquiring HSV-2 compared with people who never used them.6JAMA Internal Medicine. A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition That analysis also found that risk climbed steadily with each unprotected sexual act, underscoring that consistent use matters more than occasional use.
When researchers broke the data down by sex, the picture became more uneven. One study estimated that condom use reduced per-act transmission from men to women by about 96 percent, a strikingly high figure, but only reduced transmission from women to men by around 65 percent, a result that did not reach strong statistical confidence.7PubMed Central. Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples A separate analysis found a similar pattern: condoms appeared highly protective for women but showed no measurable protection for men in that particular dataset.8JAMA. Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women
The reason for this gap is anatomical. In men with genital herpes, the penis is the most common shedding site, and a condom covers it. In women, the virus often sheds from areas that a condom does not cover, including the vulva, perineum, and perianal skin. HSV has been isolated from multiple genital and rectal sites even during episodes without visible sores.9New England Journal of Medicine. Virologic characteristics of subclinical and symptomatic genital herpes infections So condoms are a meaningful layer of protection, especially when the male partner is the one with herpes, but they are not airtight for either direction.
How Antivirals Cut the Risk
Daily suppressive antiviral therapy is the single most studied pharmacological tool for reducing herpes transmission between partners. In the landmark trial of valacyclovir, susceptible partners of people taking the drug daily had roughly half the risk of acquiring HSV-2 compared with partners of people taking a placebo. About 1.9 percent of susceptible partners in the valacyclovir group became infected over the study period, versus 3.6 percent in the placebo group.1PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes That 48 percent reduction is often cited as the benchmark for what daily antivirals can offer.
It is worth noting that this benefit was demonstrated in otherwise healthy people with HSV-2 alone. When researchers tested daily acyclovir in people co-infected with both HSV-2 and HIV, the drug did not significantly reduce HSV-2 transmission to their partners.10The Journal of Infectious Diseases. Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial People living with HIV who also have herpes should discuss this with their provider, as the standard transmission-reduction playbook may not apply in the same way.
Combining daily antivirals with consistent condom use offers the greatest measured risk reduction. Neither strategy alone eliminates transmission, but together they address different parts of the problem: antivirals lower the amount and frequency of viral shedding, while condoms provide a physical barrier at the most common shedding sites.
Does Having Cold Sores Protect You
If you already carry HSV-1, the type behind most oral cold sores, your immune system has built some antibody response that partially cross-reacts with HSV-2. The data on this are surprisingly consistent. Women without any HSV antibodies face an annual acquisition risk around 30 percent from an infected male partner, while women with existing HSV-1 antibodies face a risk closer to 9 or 10 percent.3PubMed. Risk factors for the sexual transmission of genital herpes That is a roughly threefold reduction in susceptibility.
This cross-protection is partial, not complete. Plenty of people with HSV-1 still acquire HSV-2. But if you know you already get cold sores, you can take some comfort in the fact that your immune system already has a head start against the closely related virus. Conversely, if you have never had a cold sore and have no HSV-1 antibodies, you are in the highest-risk group if your partner has genital HSV-2.
The Growing Role of HSV-1 in Genital Herpes
Historically, genital herpes meant HSV-2. That is changing. In many high-income countries, HSV-1 has become the leading cause of first-episode genital herpes, especially among young adults. Some estimates suggest HSV-1 accounts for about half of new genital herpes cases in developed nations.11The Lancet. Genital herpes The trend appears to be rising by one to two percentage points each year in many areas.12PubMed. From HSV-2 to HSV-1: A change in the epidemiology of genital herpes
Why the shift? Fewer children are being exposed to HSV-1 during childhood than in previous generations, which means more teenagers and young adults enter sexual activity without any HSV-1 antibodies. When a person with oral HSV-1 performs oral sex on a susceptible partner, the virus can establish a genital infection. Receptive oral sex in the preceding two months was a strong predictor that a new genital herpes case would be HSV-1 rather than HSV-2.13The Journal of Infectious Diseases. Herpes Simplex Virus Type 1 as a Cause of Genital Herpes: Impact on Surveillance and Prevention
This matters for couples in two ways. First, your partner’s “herpes” might be genital HSV-1, which tends to shed less often and recur less frequently than genital HSV-2, lowering the ongoing transmission risk. Second, if you already carry oral HSV-1 yourself, you have substantial protection against acquiring a new genital HSV-1 infection, though not absolute protection.
Stress, Immunity, and Outbreak Frequency
If your partner has herpes, their outbreak frequency affects your risk because outbreaks involve high levels of viral shedding. Anything that triggers more outbreaks, in theory, creates more opportunities for transmission. Stress is the factor patients ask about most, and the research does support a connection, though it is modest.
A prospective study found that persistent stress, measured weekly, predicted herpes recurrence the following week. The association was small in absolute terms but statistically reliable. Short-term stressors, individual life events, and menstrual cycle phase did not predict recurrence, but sustained, ongoing stress did.14Archives of Internal Medicine. Persistent Stress as a Predictor of Genital Herpes Recurrence Another study looking at daily mood found that stress, anxiety, and depression predicted the appearance of genital lesions about five days before onset. However, stress did not directly predict viral shedding itself, suggesting that stress may amplify symptoms more than the underlying viral reactivation.15PubMed Central. The Effects of Daily Distress and Personality on Genital HSV Shedding and Lesions in a Randomized, Double-blind, Placebo-Controlled, Crossover Trial of Acyclovir in HSV-2 Seropositive Women
Chronic caregiving stress has also been shown to weaken the HSV-specific immune response. People caring for dementia patients had poorer T-cell responses to HSV-1 compared with matched controls.16PubMed. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1 Taken together, these studies suggest that sustained psychological pressure can tip the balance toward more frequent outbreaks, though the effect size is modest. Stress management alone is not a herpes prevention strategy, but it is one more factor worth understanding.
Why Testing Can Be Confusing
If you are the susceptible partner in a serodiscordant couple, you might assume that a blood test would reliably tell you whether you have picked up the virus. In reality, herpes blood tests have well-documented accuracy problems that trip up both patients and clinicians.
The issue centers on type-specific antibody tests. Not all commercially available assays can reliably distinguish HSV-1 from HSV-2 antibodies. In proficiency testing of antibody assays, non-glycoprotein-G-based tests showed false-positive rates for HSV-2 ranging from 14 percent to 88 percent in samples that were positive only for HSV-1.17American Journal of Obstetrics and Gynecology. Common use of inaccurate antibody assays to identify infection status with herpes simplex virus type 2 Even among the better-performing assays, discordant results between two popular platforms are common. One study found that about 18 percent of samples flagged as HSV-2 positive on one widely used test were negative on another, and the vast majority of those discordant results turned out to be false positives on closer analysis.18Sexually Transmitted Diseases. Characterization of Serum Samples With Discordant Results in 2 Herpes Simplex Virus Type 2 IgG Assays
The practical takeaway: a low-positive HSV-2 antibody result on a screening blood test should be confirmed before you change your behavior or disclose a new diagnosis. Confirmatory testing or a different type-specific assay can clarify things. And if you are trying to determine whether you have acquired herpes from a partner, a swab test during an active lesion (using PCR) is far more reliable than a blood test, especially early on when antibodies have not fully developed.
Herpes During Pregnancy
For couples considering pregnancy, the timing of infection matters enormously. A woman who acquires genital herpes for the first time during pregnancy, especially in the third trimester, faces a much higher risk of transmitting the virus to the baby during delivery than a woman who had herpes before becoming pregnant.19PubMed Central. Mother-to-Child Transmission of Herpes Simplex Virus The reason is that a new infection triggers active viral shedding at high levels before the immune system has mounted a strong response, and the mother has not yet produced antibodies that would cross the placenta and offer the baby some protection.
If your partner has herpes and you are planning a pregnancy, this is the scenario to take most seriously. Knowing your own HSV status before conceiving, using condoms and suppressive therapy during pregnancy if you are susceptible, and having an honest conversation with an obstetrician about the situation can make the risk of neonatal herpes very small. Women with longstanding herpes infections who are on suppressive therapy near the end of pregnancy have a low rate of active shedding at delivery, and cesarean delivery is reserved for cases where active lesions are present at the time of labor.
The Emotional Side of Disclosure and Risk
The medical numbers only tell part of the story. For many couples, the bigger challenge is navigating the emotional and psychological weight that comes with a herpes diagnosis. In one study of people with chronic genital herpes, roughly a third met criteria for moderate to severe anxiety, and herpes-related stigma was associated with not disclosing the diagnosis to sexual partners.20PubMed Central. Chronic genital herpes and disclosure…. The influence of stigma Disclosure tended to happen more readily in established relationships than in new ones.
If your partner has told you about their herpes status, that act itself says something. They are giving you the information you need to make an informed decision. Many people with herpes describe the disclosure conversation as far more daunting than the virus itself. For the susceptible partner, the fear of “getting it” can feel overwhelming at first, but the actual risk, once you understand the numbers and the available tools, is often more manageable than the initial anxiety suggests.
Newer Antivirals on the Horizon
The current standard, valacyclovir, works by a well-understood mechanism, but it does not eliminate shedding entirely. A newer drug called pritelivir, which works through a different pathway, showed promising results in a head-to-head trial against valacyclovir. People taking pritelivir had HSV detected on about 2.4 percent of swab days, compared with 5.3 percent on valacyclovir. Genital lesions were present on about 1.9 percent of days on pritelivir versus 3.9 percent on valacyclovir.21PubMed. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial Pritelivir has been approved in some settings for immunocompromised patients with resistant herpes, and broader trials are ongoing. If it eventually reaches general use, it could offer couples another option for lowering transmission risk beyond what current drugs achieve.
Vaginal Microbiome and Susceptibility
One factor that rarely comes up in herpes conversations is the state of the susceptible partner’s vaginal microbiome. Bacterial vaginosis, a common imbalance in vaginal bacteria, has been linked to increased susceptibility to HSV-2. In one study, women with bacterial vaginosis had roughly double the risk of acquiring HSV-2 compared with women without it, even after accounting for other risk factors like number of partners and condom use. Researchers estimated that bacterial vaginosis accounted for about a fifth of HSV-2 acquisitions in that population.22Clinical Infectious Diseases. Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
This does not mean treating bacterial vaginosis is a proven herpes prevention strategy. That connection has not been tested in a randomized trial. But it does suggest that vaginal health is one more piece of the puzzle. If you are a woman in a serodiscordant relationship and you deal with recurrent bacterial vaginosis, addressing that with your doctor may have benefits beyond the usual reasons to treat it.